These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7861665)
1. Alendronate modulates osteogenesis of human osteoblastic cells in vitro. Tsuchimoto M; Azuma Y; Higuchi O; Sugimoto I; Hirata N; Kiyoki M; Yamamoto I Jpn J Pharmacol; 1994 Sep; 66(1):25-33. PubMed ID: 7861665 [TBL] [Abstract][Full Text] [Related]
2. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679 [TBL] [Abstract][Full Text] [Related]
3. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells. Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808 [TBL] [Abstract][Full Text] [Related]
4. Effects of bisphosphonates APD and HEBP on bone metabolism in vitro. Goziotis A; Sukhu B; Torontali M; Dowhaniuk M; Tenenbaum HC Bone; 1995 Apr; 16(4 Suppl):317S-327S. PubMed ID: 7626321 [TBL] [Abstract][Full Text] [Related]
5. Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro. Tenenbaum HC; Torontali M; Sukhu B Bone; 1992; 13(3):249-55. PubMed ID: 1637572 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520 [TBL] [Abstract][Full Text] [Related]
7. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model. Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963 [TBL] [Abstract][Full Text] [Related]
8. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. Xiong Y; Yang HJ; Feng J; Shi ZL; Wu LD J Int Med Res; 2009; 37(2):407-16. PubMed ID: 19383235 [TBL] [Abstract][Full Text] [Related]
9. Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Igarashi K; Hirafuji M; Adachi H; Shinoda H; Mitani H Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):121-5. PubMed ID: 9051721 [TBL] [Abstract][Full Text] [Related]
10. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells. Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates inhibit 1,25-dihydroxyvitamin D3-induced increase of osteocalcin in plasma of rats in vivo and in culture medium of rat calvaria in vitro. Stronski SA; Bettschen-Camin L; Wetterwald A; Felix R; Trechsel U; Fleisch H Calcif Tissue Int; 1988 Apr; 42(4):248-54. PubMed ID: 2969277 [TBL] [Abstract][Full Text] [Related]
12. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Giuliani N; Pedrazzoni M; Negri G; Passeri G; Impicciatore M; Girasole G Bone; 1998 May; 22(5):455-61. PubMed ID: 9600778 [TBL] [Abstract][Full Text] [Related]
14. Osteoblast proliferation and maturation by bisphosphonates. Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901 [TBL] [Abstract][Full Text] [Related]
15. Vascular action of bisphosphonates: In vitro effect of alendronate on the regulation of cellular events involved in vessel pathogenesis. Cutini PH; Rauschemberger MB; Sandoval MJ; Massheimer VL J Mol Cell Cardiol; 2016 Nov; 100():83-92. PubMed ID: 27705747 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Kim YH; Kim GS; Jeong-Hwa B Exp Mol Med; 2002 May; 34(2):145-51. PubMed ID: 12085990 [TBL] [Abstract][Full Text] [Related]
18. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of osteoblast function in vitro by aminobisphosphonates. Orriss IR; Key ML; Colston KW; Arnett TR J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973 [TBL] [Abstract][Full Text] [Related]
20. Microgravity reduces the differentiation of human osteoblastic MG-63 cells. Carmeliet G; Nys G; Bouillon R J Bone Miner Res; 1997 May; 12(5):786-94. PubMed ID: 9144345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]